News and Comments


  Wednesday, April 28, 2010

Despite the emergence of new biological treatments for cancer, Chemotherapy is still essential, and indispensable as a major treatment for malignancies. The adverse events caused by these chemicals were found to be acceptable as a risk versus the great reward of using chemotherapy. The technological evolution that took place in the past decade and the surfacing of state-of-the-art technologies such as nanotechnology, scientists believed possibilities exist now for improving the adverse effect profiles of these therapeutic molecules. Reformulating the existing products has become an increasingly common product lifecycle-management technique. We read that a 2004 report on the U.S. drug market from BCC, Inc. projected that reformulations would grow from 62% of the market in 2003 to 79% in 2008. Finding ways to modify and improve existing products’ side effect profiles has become feasible after being essential but unreachable goal.  More...

Recent Postings



Intermune (ITMN) Trastuzumab-DM1 galapagos (GLPG) Human Longevity (HLI) Biogen Idec (BIIB) Seattle Genetics (SGEN) Cytokinetics (CYTK) ImmunoGen (IMGN) ISIS (ISIS) Rapamune Ziofpharm (ZIOP) Auspex (ASPX) Abbott Laboratories (ABT) ABBVIE (ABBV) Array Pharmaceuticals (ARRY) C4 Therapeutics Genentech Illumina (ILMN) Dynavax (DVAX) REGULUS (RGLS) Benlysta (belimumab) SYNTA (SNTA) Sanofi (SNY) GlaxoSmithKline (GSK) Sequenom (SQNM) Zerenex BIOMARIN (BMRN) Anadys (ANDS) Agenus (AGEN GUARDIAN HEALTH Sarepta (SRPT) Sangamo (SGMO) NEKTAR (NKTR)) ARCA (ABIO) Multiple Myeloma Mirati Therapeutics (MRTX) Roche (ROCHE) AERIE PHARMACEUTICALS Vitae Pharmaceuticals (VTAE) Alnylam (ALNY) Agenus (AGEN) Velcade (bortezomib) Theravance Bio Pharma (TBPH) Endometrial Cancer Bristol-Myers Squibb (BMY) Human Genome Sciences (HGSI) Intercept (ICPT) Prolor Biotech (PBTH) Aimmune Therapeutics (AIMT) TOKAI (TKAOI) Ariad (ARIA) JUNO (JUNO) Pluristem (PSTI) Sanofi (SNA) IDERA (IDRA) Revlimid (lenolidamide) Xoma (XOMA) Incyte (INCY) Galena (GALE) Idenix (IDIX) SUNESIS PHARMACEUTICALS (SNSS) KERYX (KERX) Anacor (ANAC) NANTKWEST (NK) Micromet (MITI) Roche (RHHBY) Telaprevir Vertex (VRTX) ZALTRAP™ Exelixis (EXEL) Valeant Pharmaceuticals International (VRX) Alder Biopharmaceuticals (ALDR) Biocryst (BCRX) Amgen (AMGN) Onyx (ONXX) ACADIA (ACAD) CompuGen (CGEN) VANDA (VNDA) Gilead (GILD) Herceptin ADVENTRIX (ANX) Ridaforolimus Merck (MRK) KITE (KITE) Theravance (THRX) PTC Therapeutics (PTCT) Inovio (INO) Sanofi-Aventis (SAN) Editas (EDIT) OSI (OSIP) Intrexon (XON) Dendreon (DNDN) Elan (ELN) Tysabri Ionis (IONS) Regeneron (REGN) SERES THERAPEUTICS (MCRB) HALOZYME (HALO) Jazz Pharmaceuticals (JAZZ) Prosensa (RNA) RenenxBio (RGNX)